혈관부종 치료제 시장 : 약물 유형, 투여 경로, 최종 사용자별 - 세계 예측(2025-2030년)

The Angioedema Treatment Market was valued at USD 4.69 billion in 2023, expected to reach USD 5.50 billion in 2024, and is projected to grow at a CAGR of 17.28%, to USD 14.32 billion by 2030.

The market for angioedema treatment encompasses a wide array of therapies and medications designed to manage and alleviate the symptoms of angioedema, a condition characterized by sudden swelling beneath the skin. The necessity for effective angioedema treatments has grown due to its potential severity and impact on patients' quality of life, often necessitating precise treatments for hereditary and acquired types. Applications include emergency management of acute attacks and long-term preventive treatments, with end-use spanning hospitals, clinics, and home care settings. Market growth is driven by the rising awareness and diagnosis of angioedema, advancements in biotechnology leading to novel treatment options, and increased investment in healthcare infrastructure. Latest opportunities exist in the development of targeted biologics and personalized medicine approaches, with biotech firms at the forefront, leveraging genomics and patient-specific data. Manufacturers could enhance market penetration by focusing on emerging economies where diagnosis rates are increasing. However, limitations include high costs of biologic therapies, potential side effects, and regulatory challenges that can slow the approval of new treatments. Moreover, knowledge gaps among some healthcare providers can lead to underdiagnosis or misdiagnosis, impacting market growth negatively. To overcome these challenges, innovation can be geared towards cost-effective biosimilars and enhancing genetic testing access for precise treatment plans. Research focused on uncovering molecular pathways of angioedema may yield breakthrough therapies. The market is characterized by dynamic competition with several established players and emerging startups focusing on niche segments, thus requiring constant innovation and strategic partnerships. For growth, businesses should invest in R&D for personalized treatments, expand patient education programs, and actively engage with regulatory bodies to streamline the approval processes, thereby ensuring faster access to novel therapies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Angioedema Treatment Market

The Angioedema Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing cases of hereditary angioedema (HAE)
  • Growing initiatives for improving awareness levels among the population
  • Rising incidence of disease-related genetic mutations
• Market Restraints
  • Misdiagnosis of angioedema
• Market Opportunities
  • Government initiatives to facilitate faster diagnosis and provide optimal standards of treatment
  • Development of advance therapeutics for hereditary angioedema disorders treatment
• Market Challenges
  • High cost of the drugs used for treatment

Porter's Five Forces: A Strategic Tool for Navigating the Angioedema Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Angioedema Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Angioedema Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Angioedema Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Angioedema Treatment Market

A detailed market share analysis in the Angioedema Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Angioedema Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Angioedema Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Angioedema Treatment Market

A strategic analysis of the Angioedema Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Angioedema Treatment Market, highlighting leading vendors and their innovative profiles. These include Adverum Biotechnologies, Inc., AMBOSS GmbH, Apotex Corp., Attune Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc., Cipla USA Inc., CSL Behring GmbH, Fresenius Kabi USA, LLC, Ionis Pharmaceuticals, Inc., KalVista Pharmaceuticals, Inc., Lecturio GmbH, Merck & Co., Inc., Pharming Group N.V., Sanofi-Aventis Groupe S.A., Slayback Pharma LLC, Takeda Pharmaceutical Company Limited, and Viropharma Biologics LLC.

Market Segmentation & Coverage

This research report categorizes the Angioedema Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drugs Type, market is studied across C1 Esterase Inhibitor, Kallikrein Inhibitor, and Selective Bradykinin B2 Receptor Antagonist. The C1 Esterase Inhibitor is further studied across Berinert, Cinryze, Haegarda, and Ruconest. The Kallikrein Inhibitor is further studied across Kalbitor. The Selective Bradykinin B2 Receptor Antagonist is further studied across Firazyr.
• Based on Route of Administration, market is studied across Injections and Oral.
• Based on End-User, market is studied across Clinics, Hospitals, and Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing cases of hereditary angioedema (HAE)
    • 5.1.1.2. Growing initiatives for improving awareness levels among the population
    • 5.1.1.3. Rising incidence of disease-related genetic mutations
  • 5.1.2. Restraints
    • 5.1.2.1. Misdiagnosis of angioedema
  • 5.1.3. Opportunities
    • 5.1.3.1. Government initiatives to facilitate faster diagnosis and provide optimal standards of treatment
    • 5.1.3.2. Development of advance therapeutics for hereditary angioedema disorders treatment
  • 5.1.4. Challenges
    • 5.1.4.1. High cost of the drugs used for treatment
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Angioedema Treatment Market, by Drugs Type

• 6.1. Introduction
• 6.2. C1 Esterase Inhibitor
  • 6.2.1. Berinert
  • 6.2.2. Cinryze
  • 6.2.3. Haegarda
  • 6.2.4. Ruconest
• 6.3. Kallikrein Inhibitor
  • 6.3.1. Kalbitor
• 6.4. Selective Bradykinin B2 Receptor Antagonist
  • 6.4.1. Firazyr

7. Angioedema Treatment Market, by Route of Administration

• 7.1. Introduction
• 7.2. Injections
• 7.3. Oral

8. Angioedema Treatment Market, by End-User

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Hospitals
• 8.4. Research Organizations

9. Americas Angioedema Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Angioedema Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Angioedema Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Adverum Biotechnologies, Inc.
• 2. AMBOSS GmbH
• 3. Apotex Corp.
• 4. Attune Pharmaceuticals, Inc.
• 5. BioCryst Pharmaceuticals, Inc.
• 6. Cipla USA Inc.
• 7. CSL Behring GmbH
• 8. Fresenius Kabi USA, LLC
• 9. Ionis Pharmaceuticals, Inc.
• 10. KalVista Pharmaceuticals, Inc.
• 11. Lecturio GmbH
• 12. Merck & Co., Inc.
• 13. Pharming Group N.V.
• 14. Sanofi-Aventis Groupe S.A.
• 15. Slayback Pharma LLC
• 16. Takeda Pharmaceutical Company Limited
• 17. Viropharma Biologics LLC